Filter results
Type
Audience
Last updated
Topics
-
Medical Treatment Overseas Program
Our work20 August 2025 - The Medical Treatment Overseas Program (MTOP) helps approved Australians who have a life-threatening medical condition access life-saving medical treatment overseas where treatment is not available in Australia.
-
Yellow fever
Diseases30 July 2025 - Find out how we define and monitor cases of yellow fever, and where you can learn more about this disease.
-
Aboriginal and Torres Strait Islander information and resources on sexually transmissible infections
Make STI testing your Beforeplay19 November 2025 - Find information and resources for Aboriginal and Torres Strait Islander people about sexually transmissible infections (STIs).
-
SPAP public summary documents – April 2022 – Omnigon BBraun Flexima Active
Resources › Publications16 June 2025 - This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80165F) in subgroup 3(b) of the Stoma Appliance Scheme (SAS) Schedule.
-
When active ingredient prescribing applies
Our work › Active ingredient prescribing17 June 2025 - Active ingredient prescribing (AIP) is mandatory for most prescription medications listed on the Pharmaceutical Benefits Schedule (PBS) and the Repatriation Schedule of Pharmaceutical Benefits (RPBS).
-
Smallpox
Diseases11 April 2025 - Find out how we define and monitor cases of smallpox, and where you can learn more about this disease.
-
About active and inactive medicine ingredients
Our work › Active ingredient prescribing17 June 2025 - Learn about what is, and what is not an active ingredient in prescription medicines.
-
Influenza (flu)
Diseases11 April 2025 - Find out how we define and monitor cases of influenza, how you can get vaccinated, and where you can learn more about this disease.
-
Outcomes Register – Active ingredient prescribing
Our work › Active ingredient prescribing › Excluded medicinal items and medicines for brand consideration3 October 2025 - This outcomes register is a record of the Active Ingredient Prescribing Working Group (AIPWG) review of specific medicines from 1 January 2023.
-
Anthrax
Diseases11 April 2025 - Find out how we define and monitor cases of anthrax, and where you can learn more about this disease.